Skip to Main Content

Paper Details

An Analysis of SARS-CoV-2 Vaccine Reactogenicity: Variation by Type, Dose, and History, Severity, and Recency of Prior SARS-CoV-2 Infection.
Open Forum Infect Dis
3
2022
BNT162b2, COVID, COVID-19, EPICC, SARS-CoV, SARS-CoV-2, acute respiratory syndrome coronavirus 2 infection, coronavirus 2, coronavirus disease 2019, mRNA-1273, men, patient, patients, women
Author NameAffiliation
Brian K AganInfectious Disease Clinical Research Program, Uniformed Services University of the Health Sciences
Brian K AganHenry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
Timothy H BurgessInfectious Disease Clinical Research Program, Uniformed Services University of the Health Sciences
  • 1 - 3

Datasets

Release 1.2